| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/30/2013 | CN101258166B Antibody combining with STEAP-1 protein and deriving molecule thereof |
| 01/30/2013 | CN101039689B Topical compositions and methods for epithelial-related conditions |
| 01/29/2013 | US8362305 Series of skin whitening (lightening) compounds |
| 01/29/2013 | US8362294 Phenylacetic acid derivatives |
| 01/29/2013 | US8362287 Stereoselective synthesis of vitamin D analogues |
| 01/29/2013 | US8362277 Pro-neurogenic compounds |
| 01/29/2013 | US8362274 Arylalkylamine compound and process for preparing the same |
| 01/29/2013 | US8362268 Anti-bacterial agents from benzo[d]heterocyclic scaffolds for prevention and treatment of multidrug resistant bacteria |
| 01/29/2013 | US8362267 Benzophenone thiazole derivatives useful for inhibiting formation of microtubule and method for producing the same |
| 01/29/2013 | US8362264 Compositions and methods for the treatment of disease associated with Trp-p8 expression |
| 01/29/2013 | US8362263 Crystalline S-(−)-amlodipine adipic acid salt anhydrous and preparation method thereof |
| 01/29/2013 | US8362262 Compositions to effect neuronal growth |
| 01/29/2013 | US8362256 Salts of N-[4-(1-cyanocyclopentyl)phenyl]-2-(4-pyridylmethyl)amino-3-pyridinecarboxamide |
| 01/29/2013 | US8362253 Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 01/29/2013 | US8362249 CXCR3 receptor antagonists |
| 01/29/2013 | US8362248 Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto |
| 01/29/2013 | US8362247 Prokineticin 1 receptor antagonists |
| 01/29/2013 | US8362243 Method for selective localization of active agents at and in mitochondria and corresponding active agents |
| 01/29/2013 | US8362241 Inhibitors of PI3 kinase and/or mTOR |
| 01/29/2013 | US8362236 Macrocyclic compound |
| 01/29/2013 | US8362235 Carboxamide compounds and methods for using the same |
| 01/29/2013 | US8362231 RNA interference mediating small RNA molecules |
| 01/29/2013 | US8362090 Methods and related compositions using specific flavonoids and indanes to reduce weight and inhibit lipase, α-amylase and α-glucosidase activity in mammals |
| 01/29/2013 | US8362087 Veterinary aqueous injectable suspensions containing florfenicol |
| 01/29/2013 | US8362086 Long acting injectable formulations |
| 01/29/2013 | US8362085 Method for administering an NMDA receptor antagonist to a subject |
| 01/29/2013 | US8362084 Histone deacetylases, and uses related thereto |
| 01/29/2013 | US8362083 Taste-masked docusate compositions |
| 01/29/2013 | US8362081 Methods for treating hemorrhagic conditions |
| 01/29/2013 | US8362080 Increasing glutathione levels for therapy |
| 01/29/2013 | US8362079 Method for treating hemodialysis-related oxidative stress using cystine or cysteine |
| 01/29/2013 | US8362078 Method for reducing the severity of neurological disorders |
| 01/29/2013 | US8362077 Chemical compositions for skin care emulsions and heavy duty hand cleansers |
| 01/29/2013 | US8362076 Ascorbic acid esters of resveratrol and cosmetic compositions |
| 01/29/2013 | US8362075 Cyclohexyl sulphones for treatment of cancer |
| 01/29/2013 | US8362073 Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals |
| 01/29/2013 | US8362072 BRCA1-based breast or ovarian cancer treatment agents and methods of use |
| 01/29/2013 | US8362071 Antiadhesion agents |
| 01/29/2013 | US8362070 Application of puerarin in the preparation of P2X3 mediated drugs for pain/nervous system diseases |
| 01/29/2013 | US8362068 5,5-fused arylene or heteroarylene hepatitis C virus inhibitors |
| 01/29/2013 | US8362067 3-aminoalkyl-1,3-dihydro-2H-indol-2-one derivatives, preparation thereof and therapeutic use thereof |
| 01/29/2013 | US8362066 Compounds and methods for treating protein folding disorders |
| 01/29/2013 | US8362065 Carbazole carboxamide compounds useful as kinase inhibitors |
| 01/29/2013 | US8362064 Sulfonamide compounds for the treatment of respiratory disorders |
| 01/29/2013 | US8362063 Arylsulfonamide based matrix metalloprotease inhibitors |
| 01/29/2013 | US8362062 Pharmaceutical compositions with improved dissolution |
| 01/29/2013 | US8362061 Methods for detecting sulfhydryl-containing compounds in a biological test sample |
| 01/29/2013 | US8362060 Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid |
| 01/29/2013 | US8362059 Anti-fungal formulation |
| 01/29/2013 | US8362058 Bicyclic compound, production and use thereof |
| 01/29/2013 | US8362057 Insulin resistance; atherosclerosis; cardiovascular disorders; metabolism disorders |
| 01/29/2013 | US8362056 4-heteroaryl-substituted phenoxyphenylacetic acid derivatives |
| 01/29/2013 | US8362055 Triazole compounds that modulate HSP90 activity |
| 01/29/2013 | US8362054 Therapeutic substituted lactams |
| 01/29/2013 | US8362053 Modified macrophage migration inhibitory factor inhibitors |
| 01/29/2013 | US8362052 Isoindolin-1-one derivative |
| 01/29/2013 | US8362050 Compounds and methods for modulating G protein-coupled receptors |
| 01/29/2013 | US8362049 Urea glucokinase activators |
| 01/29/2013 | US8362048 Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesis |
| 01/29/2013 | US8362047 Anti-cancer agents based on 4-(hetero)Ary1-1,2,5-oxadiazol-3-yl Amino derivatives and a method of making |
| 01/29/2013 | US8362045 5,6-diaryl pyridines substituted in the 2- and 3-position, preparation thereof and therapeutic use thereof |
| 01/29/2013 | US8362044 N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors |
| 01/29/2013 | US8362043 Use in controlling apoptosis, as antiinflammatory agents, in treating autoimmune disease, as antiischemic agents, in treating cardiovascular disorders; for example, 3(R,S)-[2(S)-(3-Benzoylamino-2-oxo-2H-pyridin-1-yl)-3-phenyl-propionylamino]-5-fluoro-4-oxo-pentanoic acid |
| 01/29/2013 | US8362042 Stable R(+)-lansoprazole amine salt and a process for preparing the same |
| 01/29/2013 | US8362040 4-phenylpiperidine derivatives as renin inhibitors |
| 01/29/2013 | US8362039 Therapeutic uses of compounds which selectively modulate the CB2 receptor |
| 01/29/2013 | US8362038 1-isopropyl-2-oxo-1,2-dihydropyridine-3-carboxamide derivatives having 5-HT4 receptor agonistic activity |
| 01/29/2013 | US8362037 2-aminopyridine analogs as glucokinase activators |
| 01/29/2013 | US8362036 Composition and method of treating a sore throat |
| 01/29/2013 | US8362035 Crystalline forms of a potent HCV inhibitor |
| 01/29/2013 | US8362034 Quinoline compound, and composition containing centipede extract or compounds isolated therefrom for prevention and treatment of cardiovascular disease |
| 01/29/2013 | US8362033 Compounds and methods to dysregulate CA2+ homeostasis for cancer treatment |
| 01/29/2013 | US8362032 Bicyclic derivatives as modulators of ion channels |
| 01/29/2013 | US8362031 Lonidamine analogues and treatment of polycystic kidney disease |
| 01/29/2013 | US8362030 Tricyclic derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP) |
| 01/29/2013 | US8362029 Opioid-containing oral pharmaceutical compositions and methods |
| 01/29/2013 | US8362028 Pseudobase benzo[c]phenanthridines with improved efficacy, stability and safety |
| 01/29/2013 | US8362027 Iontophoretic preparation for treatment of breast cancer and/or mastitis |
| 01/29/2013 | US8362026 Crystalline form of 2-chloro-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1-(2H)-pyrimidinyl]-4-fluoro-N-[[methyl(1-methyl-ethyl)amino]sulfonyl]benzamide |
| 01/29/2013 | US8362025 Compositions useful for treating disorders related to TRPA1 |
| 01/29/2013 | US8362024 Purinyl derivatives and their use as potassium channel modulators |
| 01/29/2013 | US8362023 Pyrazolo pyrimidines |
| 01/29/2013 | US8362022 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 01/29/2013 | US8362021 Method for increasing the bioavailability of benzhydryl piperazine containing compounds |
| 01/29/2013 | US8362020 Hepatitis C virus inhibitors |
| 01/29/2013 | US8362019 Synthesis and anti-proliferative effect of substituted imidazo[4,5-b]pyrazine compounds |
| 01/29/2013 | US8362018 Substituted imidazo[1,2-a]pyrazine compounds useful for the treatment of viral infections |
| 01/29/2013 | US8362017 N-[5-chloro-2-(methyloxy)phenyl]-2-{[3-(1H-tetrazol-1-yl)phenyl]oxy}acetamide; antiproliferative agents; protein kinase inhibitors; drug screening |
| 01/29/2013 | US8362016 Phenyl propionic acids as PPAR delta activators |
| 01/29/2013 | US8362015 Aminoacyl prodrug derivatives and medicaments for treatment of thromboembolic disorders |
| 01/29/2013 | US8362014 ABT-263 crystalline forms |
| 01/29/2013 | US8362013 Salt of ABT-263 and solid-state forms thereof |
| 01/29/2013 | US8362012 Benzoxazine benzimidazole derivative, a pharmaceutical composition comprising the same, and a use thereof |
| 01/29/2013 | US8362011 Tricyclic triazolic compounds |
| 01/29/2013 | US8362010 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor |
| 01/29/2013 | US8362009 Substituted diazepan orexin receptor antagonists |
| 01/29/2013 | US8362008 Amido-thiophene compounds and their use as 11-beta-HSD1 inhibitors |
| 01/29/2013 | US8362007 Substituted noribogaine |
| 01/29/2013 | US8362005 Monocyclic amide CGRP receptor antagonists |
| 01/29/2013 | US8362004 Piperazine analogs as broad-spectrum influenza antivirals |